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www.jacc-interventions.org to view.Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction
Presenting Late After Symptom Onset113Steffen Desch, Thomas Stiermaier, Suzanne de Waha, Philipp Lurz, Matthias Gutberlet,
Marcus Sandri, Norman Mangner, Enno Boudriot, Michael Woinke, Sandra Erbs,
Gerhard Schuler, Georg Fuernau, Ingo Eitel, Holger ThieleIt is unclear whether routine manual thrombus aspiration reduces microvascular obstruction (MVO) in
patients with subacute ST-segment elevation myocardial infarction (STEMI). A total of 152 patients
with STEMI presenting 12 to 48 h after symptom onset were randomized to primary percutaneous
coronary intervention (PCI) with or without thrombus aspiration. The primary endpoint, extent of
MVO assessed by cardiac magnetic resonance imaging, was not signiﬁcantly different between
groups. Routine thrombus aspiration before PCI thus failed to show a beneﬁt for reperfusion success
in patients with STEMI presenting late after symptom onset.n EDITORIAL COMMENT
The Oculothrombotic Reﬂex: Why We Will Never Stop Aspirating Coronary Thrombi 123
James C. Blankenship
Outcomes From Selective Use of Thrombectomy in Patients Undergoing Primary
Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction:
An Analysis of the British Cardiovascular Intervention Society/National Institute for
Cardiovascular Outcomes Research (BCIS-NICOR) Registry, 2006–2013126Alex Sirker, Mamas Mamas, Chun Shing Kwok, Evangelos Kontopantelis, Peter Ludman,
David Hildick-Smith, on behalf of the British Cardiovascular Intervention Society (BCIS)The impact of coronary thrombectomy on mortality in ST-segment elevation myocardial infarction
(STEMI) is not deﬁnitively established. The U.K. national registry, therefore, was used to study
98,176 patients treated with primary percutaneous coronary intervention. Patients were grouped by
whether they received thrombectomy or not, based on physician selection. The use of
thrombectomy was not associated with any signiﬁcant difference in mortality at 30 days or 1 year,
using statistical modeling, even in the “simple” (manual aspiration) thrombectomy subgroup.
Findings are consistent with the lack of clinical beneﬁts in recent large randomized controlled trials
of routine aspiration thrombectomy in STEMI.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
The Rise and Fall of Aspiration Thrombectomy 135
Dharam J. Kumbhani, Anthony A. Bavry
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James B. Hermiller, Mitchell W. Krucoff, Dean J. Kereiakes, Stephan Windecker,
P. Gabriel Steg, Robert W. Yeh, David J. Cohen, Donald E. Cutlip, Joseph M. Massaro,
Wen-Hua Hsieh, Laura Mauri, on behalf of the DAPT Study InvestigatorsThe authors examined outcomes, post-hoc, among 4,703 randomized everolimus-eluting stent
(EES)–treated subjects in the DAPT (Dual Antiplatelet Therapy) study. Among EES-treated patients,
continued thienopyridine reduced stent thrombosis (0.3% vs. 0.7%; p ¼ 0.04) and myocardial
infarction (MI) (2.1% vs. 3.2%; p ¼ 0.01) versus placebo, but not a composite of death, MI, or
stroke (4.3% vs. 4.5%; p ¼ 0.42) and increased moderate/severe bleeding (2.5% vs. 1.3%;
p ¼ 0.01) 12 to 30 months post-stenting. These outcomes were consistent among EES and other
drug-eluting stents (interaction p ¼ 0.76 stent thrombosis; p ¼ 0.11 MI; p ¼ 0.46 bleeding). In
EES-treated subjects, continued thienopyridine plus aspirin beyond 1 year (vs. aspirin alone)
reduced stent thrombosis and MI and increased bleeding.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
Is Prolonged DAPT Apt or a Study in Zero-Sum Games? 148
David R. Holmes, Jr., Charanjit S. RihalSTRUCTURAL Effects of Mechanical Ventilation on Heart Geometry and Mitral Valve Leaﬂet
Coaptation During Percutaneous Edge-to-Edge Mitral Valve Repair151Johannes Patzelt, Yingying Zhang, Peter Seizer, Harry Magunia, Andreas Henning,
Veronika Riemlova, Tara A.E. Patzelt, Marc Hansen, Michael Haap, Reimer Riessen,
Henning Lausberg, Tobias Walker, Joerg Reutershan, Christian Schlensak,
Christian Grasshoff, Dan I. Simon, Peter Rosenberger, Juergen Schreieck,
Meinrad Gawaz, Harald F. LangerMechanical ventilation during percutaneous mitral valve repair (PMVR) allows modiﬁcation of heart
geometry. In 50 patients undergoing PMVR, increasing positive end-expiratory pressure levels
resulted in a signiﬁcant reduction of left ventricular and mitral valve annulus diameter.
Accordingly, the authors observed a very robust ampliﬁcation in mitral valve leaﬂet coaptation
length. This increase in coaptation length was more pronounced in mitral regurgitation with
functional or mixed genesis. Importantly, a coaptation length $4.9 mm was associated with
signiﬁcantly reduced PMVR procedure time. In conclusion, we describe a novel ventilation
maneuver to amplify mitral valve coaptation length, which potentially facilitates the PMVR
procedure.
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JANUARY 25, 2016 VOLUME 9, NUMBER 2Incidence, Predictive Factors, and Effect of Delirium After Transcatheter
Aortic Valve Replacement160Masieh Abawi, Freek Nijhoff, Pierfrancesco Agostoni, Marielle H. Emmelot-Vonk,
Rehana de Vries, Pieter A. Doevendans, Pieter R. StellaPatients undergoing surgical valve replacement appear at higher risk of post-operative delirium
(POD). Little is known regarding the effect of POD on the clinical outcomes after transcatheter
aortic valve replacement (TAVR). By means of this single-center retrospective study, the authors
sought to investigate the incidence, predictive factors, and effect of POD among 268 consecutive
patients treated with TAVR. The incidence of POD after TAVR was 13.4%. Nontransfemoral
approach, current smoking, carotid artery disease, atrial ﬁbrillation, and age were found to be
independent predictors of POD. In addition, POD was associated with prolonged in-hospital stay
and poorer midterm outcomes.
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Could a “Simpliﬁed” Transcatheter Aortic Valve Replacement Procedure Eliminate
Post-Operative Delirium?169David A. Wood
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Christian Frerker, Michael Schlüter, Oscar D. Sanchez, Sebastian Reith, Maria E. Romero,
Elena Ladich, Jörg Schröder, Tobias Schmidt, Felix Kreidel, Michael Joner,
Renu Virmani, Karl-Heinz KuckStroke has been observed, if rarely, after MitraClip therapy. Using cerebral protection with a
dual-ﬁlter system during MitraClip implantation revealed embolic debris potentially conducive to
cerebrovascular events in all 14 patients studied. Most prevalent debris types were acute
thrombus, foreign material likely originating from the hydrophilic device coating, and valve/atrial
wall tissue. No strokes, transient ischemic attacks, or deaths occurred during 8.4 months (median)
of follow-up observation. Our ﬁndings warrant further study to assess the impact of cerebral
protection on the incidence of cerebrovascular events after MitraClip therapy.n EDITORIAL COMMENT
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Research or Clinical Tool?180Nicolas M. Van Mieghem, Lennart van Gils
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dissection may be linked to the clinical outcome and endoleak development. The authors
postulated that some procedural factors could affect the clinical outcome, major adverse events
(MAE), and frequency of the development of endoleaks. Some procedural factors were found to
inﬂuence aortic remodeling and clinical outcomes in acute aortic dissection, but not in chronic
aortic dissection. In particular, post-dilation of the stent graft augmented the false lumen (FL)
thrombosis, without affecting or inﬂuencing MAEs or endoleak development, and left subclavian
artery embolization had a direct inﬂuence on the improvement of FL thrombosis and reduced
endoleak development but not MAE (p ¼ 0.05). These new ﬁndings may help to predict aortic
remodeling and clinical outcome after TEVAR.n EDITORIAL COMMENT
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